MapLight Therapeutics (MPLT) lifts GC stake with 31K options

Rhea-AI Filing Summary

MapLight Therapeutics, Inc. (MPLT) reported that its General Counsel, Kristopher Hanson, received equity awards on August 17, 2026. He was granted 31,395 stock options with an exercise price of $11.245 per share, expiring August 16, 2036, and a separate award of 7,730 restricted stock units (RSUs). The options and RSUs vest over time, beginning July 1, 2027, subject to his continued service, and his direct voting common stock holdings increased to 153,553 shares after the RSU grant.

Insider Trade Summary

Net Buyer: 7,730 shares

Net Buy 2 txns

Insider Hanson Kristopher

Role General Counsel

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (right to buy) F3	31,395	$0.00	$0.00
Grant/Award	Voting Common Stock F1, F2	7,730	$0.00	$0.00

Holdings After Transaction: Employee Stock Option (right to buy) — 31,395 shares (Direct); Voting Common Stock — 153,553 shares (Direct)

Footnotes (3)

1. F1. Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on July 1, 2027, and 1/16th of the RSUs shall vest on each subsequent October 1, January 1, April 1 and July 1 thereafter, subject to the Reporting Person's continued service through each vesting date.
2. F2. Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.
3. F3. 1/4th of the total shares underlying the option shall vest on July 1, 2027, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.

Key Figures

Options granted: 31,395 shares Option exercise price: $11.245 per share Option expiration: August 16, 2036 +4 more

7 metrics

Options granted 31,395 shares Employee stock options granted to General Counsel on August 17, 2026

Option exercise price $11.245 per share Exercise price for 31,395 employee stock options

Option expiration August 16, 2036 Expiration date of employee stock options

RSUs granted 7,730 units Restricted stock unit award to General Counsel on August 17, 2026

Shares held after RSU grant 153,553 shares Direct voting common stock holdings following non-derivative acquisition

Initial RSU vest date July 1, 2027 1/4 of RSUs vest on this date, remainder quarterly thereafter

Initial option vest date July 1, 2027 1/4 of option shares vest on this date, remainder monthly thereafter

Key Terms

restricted stock unit ("RSU"), voting common stock, Employee Stock Option (right to buy)

3 terms

restricted stock unit ("RSU") financial

"Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall"

voting common stock financial

"Each RSU represents a contingent right to receive one share of voting common"

Employee Stock Option (right to buy) financial

"security_title": "Employee Stock Option (right to buy)"

FAQ

What equity awards did MPLT grant to General Counsel Kristopher Hanson?

Kristopher Hanson received 31,395 stock options at an exercise price of $11.245 and 7,730 RSUs on August 17, 2026. Both awards vest over time starting July 1, 2027, contingent on his continued service.

How many MapLight Therapeutics (MPLT) options were granted to Kristopher Hanson and at what price?

He was granted 31,395 employee stock options with an exercise price of $11.245 per share. These options expire on August 16, 2036, and vest over several years beginning July 1, 2027.

What are the vesting terms of Kristopher Hanson’s RSUs at MPLT?

The 7,730 RSUs vest 1/4 on July 1, 2027, with 1/16 vesting on each subsequent October 1, January 1, April 1, and July 1. Vesting requires Hanson's continued service through each vesting date.

How do Kristopher Hanson’s options at MPLT vest over time?

For the 31,395 options, 1/4 of the underlying shares vest on July 1, 2027, and 1/48 vest monthly thereafter on the same calendar day, subject to his continued service with MapLight Therapeutics.

How many MPLT common shares does Kristopher Hanson own after these awards?

Following the RSU grant, Kristopher Hanson directly holds 153,553 shares of MPLT voting common stock. Each RSU represents a contingent right to receive one additional share upon vesting, increasing his potential future share ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/19/2026 - 06:35 PM Accepted by SEC EDGAR 08/19/2026 - 06:35 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hanson Kristopher

(Last) (First) (Middle)

C/O MAPLIGHT THERAPEUTICS, INC.

800 CHESAPEAKE DRIVE

(Street)

REDWOOD CITY CALIFORNIA 94063

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MapLight Therapeutics, Inc. [ MPLT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Voting Common Stock	08/17/2026		A		7,730(1)	A	$0(2)	153,553	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$11.245	08/17/2026		A		31,395		(3)	08/16/2036	Voting Common Stock	31,395	$0	31,395	D

Explanation of Responses:

1. Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on July 1, 2027, and 1/16th of the RSUs shall vest on each subsequent October 1, January 1, April 1 and July 1 thereafter, subject to the Reporting Person's continued service through each vesting date.

2. Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.

3. 1/4th of the total shares underlying the option shall vest on July 1, 2027, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.

	/s/ Kristopher L. Hanson, Attorney-in-Fact	08/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)